title: The combination of chloroquine and minocycline, a therapeutic option in cerebrospinal infection of Whipple's disease refractory to treatment with ceftriaxone, meropenem and co-trimoxazole.
authors.forename: Gerhard E
authors.initials: GE
authors.lastname: Feurle
authors.forename: Verena
authors.initials: V
authors.lastname: Moos
authors.forename: Thomas
authors.initials: T
authors.lastname: Schneider
authors.forename: Florence
authors.initials: F
authors.lastname: Fenollar
authors.forename: Didier
authors.initials: D
authors.lastname: Raoult
mesh_terms: D000900:Anti-Bacterial Agents / Q000008:administration & dosage* / Q000494:pharmacology; D002443:Ceftriaxone / Q000008:administration & dosage / Q000494:pharmacology; D002493:Central Nervous System Diseases / Q000188:drug therapy*; D002738:Chloroquine / Q000008:administration & dosage* / Q000494:pharmacology; D024881:Drug Resistance, Bacterial; D004359:Drug Therapy, Combination / Q000379:methods; D006801:Humans; D008297:Male; D000077731:Meropenem; D008826:Microbial Sensitivity Tests; D008911:Minocycline / Q000008:administration & dosage* / Q000494:pharmacology; D013845:Thienamycins / Q000008:administration & dosage / Q000494:pharmacology; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000008:administration & dosage / Q000494:pharmacology; D008061:Whipple Disease / Q000188:drug therapy*
chemical_list: D000900:Anti-Bacterial Agents; D013845:Thienamycins; D002443:Ceftriaxone; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D002738:Chloroquine; D000077731:Meropenem; D008911:Minocycline